76.22

0.79% -0.61

After Hours: 76.50 0.28 +0.37%

Lantheus Holdings Inc (LNTH)

Overview News Price History Option Chain Financials Why LNTH Down? Discussions Forecast

Lantheus Holdings Inc stock is traded at $76.22, with a volume of 1.10M. It is down -0.79% in the last 24 hours and down -34.68% over the past month. Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Previous Close:

$76.83

Open:

$76.82

24h Volume:

1.10M

Relative Volume:

1.27

Market Cap:

$5.30B

Revenue:

$1.44B

Net Income/Loss:

$428.48M

P/E Ratio:

53.30

EPS:

1.43

Net Cash Flow:

$366.85M

1W Performance:

-9.35%

1M Performance:

-34.68%

6M Performance:

-4.33%

1Y Performance:

+11.76%

1-Day Range:

$75.38

$77.17

1-Week Range:

$75.38

$85.38

52-Week Range:

$50.20

$126.89

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name

Lantheus Holdings Inc

Sector

Healthcare (1204)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

978 671-8001

Address

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Employee

834

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

LNTH's Discussions on Twitter

Compare LNTH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNTH	76.22	5.30B	1.44B	428.48M	366.85M	1.43
ZTS	176.42	79.51B	9.15B	2.43B	2.31B	4.92
TAK	13.53	42.89B	30.27B	1.93B	3.45B	0.444
HLN	9.43	42.57B	14.26B	1.55B	0	0.3327
TEVA	16.49	18.51B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.00	15.37B	15.24B	-646.50M	1.88B	1.53

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy
May-09-22	Initiated	B. Riley Securities	Buy
Apr-13-22	Initiated	Truist	Buy
Feb-01-21	Initiated	SVB Leerink	Outperform
Jun-29-20	Resumed	Jefferies	Buy
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform
Sep-23-16	Resumed	Credit Suisse	Neutral
Feb-24-16	Reiterated	RBC Capital Mkts	Outperform
Dec-11-15	Downgrade	Credit Suisse	Outperform → Neutral
Sep-30-15	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-20-15	Initiated	Credit Suisse	Outperform
Jul-20-15	Initiated	Jefferies	Buy
Jul-20-15	Initiated	RBC Capital Mkts	Outperform
Jul-20-15	Initiated	Robert W. Baird	Outperform
Jul-20-15	Initiated	Wells Fargo	Outperform

View All

Lantheus Holdings Inc Stock (LNTH) Latest News

Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition in Lantheus Ho - GuruFocus.com

Nov 14, 2024

Black Swift Group LLC Invests $1.21 Million in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat

Nov 14, 2024

Lantheus Holdings' SWOT analysis: radiopharmaceutical leader faces market shifts - Investing.com India

Nov 14, 2024

Nov 13, 2024

Lantheus To Present At The Jefferies London Healthcare Conference - Barchart

Nov 13, 2024